Exome Asset Management LLC Madrigal Pharmaceuticals, Inc. Transaction History

Exome Asset Management LLC

  • $146 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$193.33 - $291.99 $560,657 - $846,771
2,900 Added 36.71%
10,800 $3.03 Billion
Q1 2024

May 15, 2024
SELL
$171.37 - $283.23 $908,603 - $1.5 Million
-5,302 Reduced 40.16%
7,900 $2.11 Billion
Q4 2023

Feb 14, 2024
BUY
$120.4 - $237.13 $1.59 Million - $3.13 Million
13,202 New
13,202 $3.05 Billion

Others Institutions Holding MDGL

# of Institutions
298
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.9B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Exome Asset Management LLC Portfolio

Follow Exome Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exome Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exome Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email